LOS ANGELES, CA–(Marketwired – Jun 7, 2013) – MMRGlobal, Inc. (OTCQB: MMRF) (“MMR”) has announced that as previously disclosed, MyMedicalRecords, Inc., a wholly owned subsidiary of MMRGlobal, sued WebMD Health Corp. and WebMD Health Services Group, Inc. (collectively, “WebMD”) in federal district court for patent infringement. MMR has entered into a written agreement with WebMD to dismiss the case without prejudice to re-filing the same case again, in order to continue to try and resolve the matter without the timing constraints imposed by the lawsuit. As the dismissal is without prejudice, MMR retains the right to re-file the litigation at any time. The complaint was filed in the United States District Court for the Central District of California, case number CV 13-00979 (ODW/SHx), on February11, 2013, and is available on the court’s website http://www.pacer.gov/.
Robert H. Lorsch, CEO of MMRGlobal, said, “As a former arbitrator for the American Arbitration Association, I learned from firsthand experience that resolving disputes privately at a table is always my preferred course of action when compared to spending millions of dollars in legal fees over years in a courtroom. As the inventor of MMR’s health IT patent portfolio, I see this announcement as a positive development for the Company. The purpose in filing our patents has always been to protect MMR’s constitutional right to own property and sell the products and services which include our patented IP. We hope this will be the first of many similar opportunities to build business relationships at the negotiating table with hospitals, providers, vendors and others who may be infringing on the Company’s IP.”
The Company also announced that domestically, it has initiated service of its patent infringement complaint recently filed against Jardogs LLC, a subsidiary of Allscripts, case number CV 13-3560, which can also be found at http://www.pacer.gov/. According to the complaint, Jardogs provides health information services to consumers and healthcare providers and Jardogs, while infringing on MMR’s patent, also has induced others including Allscripts, distributors, agents, resellers and users to infringe one or more claims of the patent.
Internationally, MMR has retained the Sydney, Australia-based law firm of Rockwell Olivier, which earlier this week advised the National E-Health Transition Authority in Australia (“NEHTA”) that based on preliminary investigations, the personally controlled electronic health record system deployed by NEHTA appears in many respects to be using the same methods as MMR’s MyMedicalRecords Australian patents, specifically numbers 2006202057 and 2008202401.
“While we continue to pursue additional licensing opportunities, we remain confident in the value of our seven issued U.S. patents and global patents in 12 countries around the world. MMR remains committed to aggressively leveraging our portfolio of health information technology patents in the marketplace to obtain the highest value for our stockholders, employees and vendors,” Lorsch added.
MMR is a leading provider of Personal Health Records, MyEsafeDepositBox storage solutions, and MMRPro document management and imaging systems for healthcare professionals. The MMR Patent Portfolio includes seven issued U.S. patents — U.S. Patent Nos. 8,301,466; 8,352,287; 8,352,288; 8,121,855; 8,117,646; 8,117,045; and 8,321,240 — as well as additional applications and continuation applications including nearly 400 claims. The patents involve inventions pertaining to Personal Health Records, Patient Portals and other Electronic Health Record systems. MMR also has been granted patents and has other pending applications in countries of commercial interest including Australia, Singapore, New Zealand, Mexico, Japan, Canada, Hong Kong, South Korea, Israel, and European nations. The Company’s health IT patent portfolio was the subject of a May 2, 2013 report on Personal Health Records that concluded that the value of the Company’s U.S. patents could reach between $800 million to $1.1 billion in revenue (available at http://michaelbass.com/PDF/Patent_Valuation.pdf).
MMRGlobal, Inc., through its wholly-owned operating subsidiary, MyMedicalRecords, Inc., provides secure and easy-to-use online Personal Health Records (“PHRs”) and electronic safe deposit box storage solutions, serving consumers, healthcare professionals, employers, insurance companies, financial institutions, retail pharmacies, and professional organizations and affinity groups. The MyMedicalRecords PHR enables individuals and families to access their medical records and other important documents, such as birth certificates, passports, insurance policies and wills, anytime from anywhere using the Internet. MyMedicalRecords is built on proprietary, patented technologies to allow documents, images and voicemail messages to be transmitted and stored in the system using a variety of methods, including fax, phone, or file upload without relying on any specific electronic medical record platform to populate a user’s account. The Company’s professional offering, MMRPro, is designed to give physicians’ offices an easy and cost-effective solution to digitizing paper-based medical records and sharing them with patients through an integrated patient portal. Through its merger with Favrille, Inc. in January 2009, the Company acquired intellectual property biotech assets that include anti-CD20 antibodies and data and samples from its FavId™/Specifid™ vaccine clinical trials for the treatment of B-Cell Non-Hodgkin’s lymphoma. To learn more about MMRGlobal, Inc. visit www.mmrglobal.com. View demos and video tutorials of the Company’s products and services at www.mmrtheater.com.